US › Healthcare

Anteris Technologies Global Corp. Common Stock (AVR)

US · Healthcare · Medical Instruments & Supplies

$8.280.00%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$494,000
Revenue YoY
-11.2%
Net profit
$-23.0M
Profit YoY
-5.3%
EPS
$-0.28
EPS estimate
$-0.27
Net margin
-4,660.7%

EPS came in at -0.28 against a street estimate of -0.27 — a miss of 2.7%.

Key statistics

Market cap
$806.0M
Forward P/E
0.0
P/B
2.74
Book value
$2.86
EPS (TTM)
$-2.22
52-week high
$11.05
52-week low
$3.17
50-day MA
$9.17
200-day MA
$6.35
Beta
0.73

Analyst view

Analysts rate Anteris Technologies Global Corp. Common Stock a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $15.33.

Shareholding

Insiders
16.47%
Institutions
66.45%

Largest institutional holders

FundStake
L1 Capital Pty Ltd8.00%
Nantahala Capital Management, LLC5.68%
Sio Capital Management, LLC5.53%
BlackRock Inc5.02%
ADAR1 Capital Management LLC3.89%
Perceptive Advisors LLC3.52%
Bvf Inc3.08%
RA Capital Management, LLC3.08%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Anteris Technologies Global Corp. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.